Skip to main content

Table 1 CT findings in the 30 patients of study population

From: The role of 18-FDG PET/CT assessment of functional brain metabolism in cancer patients after chemotherapy

Primary

Adenocarcinoma of the spine

1

3.3%

Ovarian cancer

1

3.3%

Breast cancer

9

30.0%

Bronchogenic carcinoma

8

26.6%

Colonic cancer

1

3.3%

Hepatic focal lesions

1

3.3%

Lacrimal gland neoplasm

1

3.3%

Lymphoma

4

13.3%

Palatal melanoma

1

3.3%

Parotid neoplasm

2

6.7%

RCC

1

3.3%